KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank92
3Y CAGR+14.3%
5Y CAGR+27.5%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+14.3%/yr
vs +44.2%/yr prior
5Y CAGR
+27.5%/yr
Recent deceleration
Acceleration
-29.8pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
3.4x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.07 | +86.7% |
| 2024 | 0.04 | -30.7% |
| 2023 | 0.05 | +15.6% |
| 2022 | 0.04 | +92.5% |
| 2021 | 0.02 | +17.0% |
| 2020 | 0.02 | +3418.6% |
| 2019 | 0.00 | -94.5% |
| 2018 | 0.01 | - |
| 2017 | 0.00 | -100.0% |
| 2016 | 0.21 | - |